Although the ink isn’t quite dry yet, Tennessee Oncology officials have announced their intent to acquire Chattanooga Oncology & Hematology Associates for an undisclosed sum, a deal expected to be finalized in the next few weeks.
The transaction is expected to close Jan. 1, according to a company statement. COHA will then change its name to Tennessee Oncology and will add four locations, 13 physicians and nearly 100 employees to the Nashville-based company’s ranks, folks now working in COHA’s Chattanooga and Northwest Georgia offices. Tennessee Oncology today has about 60 oncologists and hematologists on staff.
“COHA initiated discussions with us several months ago, and we believe this merger is a win-win for both parties as our two practices share very similar philosophies, especially when it comes to making sure patients always come first,” said Dr. Jeff Patton, Tennessee Oncology's CEO.
The parties aren’t strangers. According to their statement, “Tennessee Oncology has a longstanding research alliance with COHA through a strategic partnership with the Sarah Cannon Research Institute, and will now offer expanded access to clinical trials and specialized services to all COHA patients. This includes access to Tennessee Oncology’s Park Pharmacy, a full-service pharmacy dedicated to oncology and hematology medications not commonly stocked in community retail pharmacies.”